Human Mammary Carcinoma
Showing 1 - 25 of >10,000
Breast Tumor, Breast Cancer, Breast Carcinoma Trial in Indianapolis (Enhanced Usual Care, Acceptance Commitment Therapy,
Recruiting
- Breast Neoplasm
- +11 more
- Enhanced Usual Care
- +2 more
-
Indianapolis, IndianaIndiana University-Purdue University Indianapolis
Jul 23, 2022
ALDH1A1 Expression in Invasive Mammary Carcinoma
Enrolling by invitation
- Breast Cancer
-
Sohag, EgyptFaculty of Medicine
Nov 12, 2023
Lactation Trial in Seattle (Cimetidine 200 MG)
Recruiting
- Lactation
- Cimetidine 200 MG
-
Seattle, WashingtonUniversity of Washington
Sep 20, 2023
Mammary Tumors, Human Trial in Tianjin (eutidrone etoposide bevacizumab)
Recruiting
- Mammary Neoplasms, Human
- eutidrone etoposide bevacizumab
-
Tianjin, Tianjin, ChinaYehui Shi
Mar 10, 2023
Nasopharyngeal Carcinoma Trial (Envafolimab and recombinant human endostatin combined with chemoradiotherapy)
Not yet recruiting
- Nasopharyngeal Carcinoma
- Envafolimab and recombinant human endostatin combined with chemoradiotherapy
- (no location specified)
Sep 23, 2023
Primary Hepatocellular Carcinoma, Portal Vein Thrombosis Trial (Recombinant human adenovirus type 5 + TACE)
Not yet recruiting
- Primary Hepatocellular Carcinoma
- Portal Vein Thrombosis
- Recombinant human adenovirus type 5 + TACE
- (no location specified)
May 14, 2023
Multidimensional and Multimodal Profiling of Oropharyngeal
Not yet recruiting
- Oropharyngeal Carcinoma
- Human Papilloma Virus
-
Palo Alto, CaliforniaStanford University
May 25, 2023
Locally Advanced Basal Cell Carcinoma Trial in Philadelphia (biological, procedure, other)
Not yet recruiting
- Locally Advanced Basal Cell Carcinoma
- Cemiplimab
- +3 more
-
Philadelphia, PennsylvaniaThomas Jefferson University Hospital
Jun 28, 2023
Primary Hepatocellular Carcinoma Trial (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)), camrelizumab for
Not yet recruiting
- Primary Hepatocellular Carcinoma
- Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
- camrelizumab for Injection
- (no location specified)
Nov 13, 2023
HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Orange (Intensity-Modulated Radiation Therapy (IMRT))
Recruiting
- HPV Positive Oropharyngeal Squamous Cell Carcinoma
- Intensity-Modulated Radiation Therapy (IMRT)
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
Nov 4, 2022
Invasive Mammary Carcinoma, Metastatic Breast Cancer Trial in Nashville (Capecitabine, Endocrine-therapy, MammoPrint ® and
Not yet recruiting
- Invasive Mammary Carcinoma
- Metastatic Breast Cancer
- Capecitabine
- +2 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Jan 11, 2023
HPV Associated Anogenital Pathology in Female Patients and
Recruiting
- Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma
- Non-Interventional Study
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 2, 2023
Cervical Carcinoma in Shatby University Hospital and Its
Completed
- Cervical Cancer
- real time PCR
-
Alexandria, EgyptHossam Hassan El Sokkary
Sep 9, 2022
Squamous Cell Carcinoma of the Oropharynx, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Carmel, Indianapolis (44
Recruiting
- Squamous Cell Carcinoma of the Oropharynx
- HPV Positive Oropharyngeal Squamous Cell Carcinoma
- 44 doses of radiation
- 54 doses of radiation
-
Carmel, Indiana
- +1 more
Oct 5, 2022
Internal Mammary or Supraclavicular Lymphadenectomy
Recruiting
- Ovarian Cancer Stage IV
- Lymph Node Metastases
- debulking surgery
-
Seoul, 시/도/주, Korea, Republic ofSeoul National University Hospital
Aug 10, 2021
CD133 Expression in Mammary Invasive Ductal Carcinoma
Recruiting
- Breast Cancer
-
Sohag, Egypt
- +1 more
May 5, 2021
HPV-Associated Oropharyngeal Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Neck Trial in United States (diagnostic
Recruiting
- HPV-Associated Oropharyngeal Squamous Cell Carcinoma
- Squamous Cell Carcinoma of the Neck
- F-FMISO PET/CT Scan
- +5 more
-
Hartford, Connecticut
- +9 more
Jan 31, 2023
Kidney Cancer, Clear Cell Renal Cell Carcinoma Metastatic, Synchronous Tumor Trial in Seoul (Cytoreductive
Recruiting
- Kidney Cancer
- +2 more
- Cytoreductive nephrectomy±metastasectomy
- Human-derived materials sampling
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Mar 2, 2023
Advanced Solid Tumor, Hepatocellular Carcinoma Trial in Los Angeles (TORL-4-500)
Not yet recruiting
- Advanced Solid Tumor
- Hepatocellular Carcinoma
-
Los Angeles, CaliforniaUCLA - JCCC Clinical Research Unit
Aug 23, 2023
Nasopharyngeal Carcinoma Trial in China (Endostatin and Capecitabine)
Recruiting
- Nasopharyngeal Carcinoma
- Endostatin and Capecitabine
-
Hangzhou, Zhejiang, China
- +6 more
Aug 21, 2022
Basal Cell Carcinoma Trial in Spain (PHITAH, PHIT, Biobrane)
Recruiting
- Basal Cell Carcinoma
- PHITAH
- +2 more
-
Marbella, Málaga, Spain
- +3 more
Oct 10, 2022
Head and Neck Carcinoma, Adult Disease Trial in Villejuif (HPVDC injection level dose 1, injection level dose 1, HPVDC
Recruiting
- Head and Neck Carcinoma
- Adult Disease
- HPVDC injection level dose 1
- +3 more
-
Villejuif, FranceGustave Roussy
Aug 17, 2023
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus-Related Carcinoma, Locally
Recruiting
- Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +5 more
- Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101
- Pembrolizumab
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Advanced Solid Tumors Cancer, Advanced Urothelial Carcinoma, Oral Drug Administration Trial in New York (FX-909)
Not yet recruiting
- Advanced Solid Tumors Cancer
- +3 more
-
New York, New YorkMemorial Slone Kettering Cancer Center
Jun 26, 2023